Materiały źródłowe

• #1 Practice guideline update summary: Mild cognitive impairment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/

  MCI prevalence was 6.7% for ages 6064, 8.4% for 6569, 10.1% for 7074, 14.8% for 7579, and 25.2% for 8084. […] No high-quality evidence exists to support pharmacologic treatments for MCI. In patients with MCI, exercise training (6 months) is likely to improve cognitive measures and cognitive training may improve cognitive measures. […] Clinicians may choose not to offer cholinesterase inhibitors (Level B); if offering, they must first discuss lack of evidence (Level A). […] For patients diagnosed with MCI, clinicians should wean patients from medications that can contribute to cognitive impairment (where feasible and medically appropriate) and treat modifiable risk factors that may be contributing (Level B). […] For patients diagnosed with MCI, clinicians should recommend regular exercise (twice/week) as part of an overall approach to management (Level B). […] In patients with MCI, clinicians may recommend cognitive interventions (Level C).

• #2 Mild Cognitive Impairment (MCI): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17990-mild-cognitive-impairment

  Mild cognitive impairment (MCI) happens when you have a slight decline in your mental abilities, like memory and completing complex tasks. MCI has several possible causes, some of which are treatable. A healthcare provider can evaluate you for a diagnosis and possible treatment. […] The treatment for MCI depends on the underlying cause if known. However, some cases of MCI from neurodegenerative diseases cant be reversed. But if your mental changes are due to causes like an infection, sleep problems, mood or medication side effects, your healthcare provider will come up with a treatment plan. […] The U.S. Food and Drug Administration (FDA) hasnt currently approved any medications to directly treat mild cognitive impairment. But there are treatment plans that include nonmedication options to improve cognition. They vary based on the underlying cause of MCI. Researchers are hopeful that Alzheimers disease medications could also help with MCI. They are currently studying this. […] Researchers are actively studying treatment options for MCI. You may be able to join a clinical trial. Talk to your provider about your options.

• #3 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  Mild cognitive impairment (MCI) is a syndrome which, depending on various neurobiological, psychological and social factors, carries a high risk of developing into dementia. […] As far as diagnostic uncertainty and the heterogeneous underlying pathophysiological mechanisms are concerned, only limited therapeutic options are currently available. […] For MCI as a prodromal syndrome of AD, clinical trials with disease modifying drugs that target underlying pathological mechanisms such as amyloid-beta accumulation and neurofibrillary tangle formation may help develop effective treatment options in the future. […] Nevertheless, a lack of approved pharmacotherapeutic options has led to specific interventions that focus on patient education and life-style related factors receiving increasing attention.

• #4 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. […] The medicines are approved for people with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease. Known as monoclonal antibodies, they include:

• #5 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] In some cases, memory and thinking problems may be caused by conditions that are treatable. For example, a bad reaction to medication, emotional problems, drinking too much alcohol, blood clots or tumors in the brain, or a head injury can all cause serious memory problems that can be resolved with treatment. […] There is currently no treatment or medication for MCI, but there are things you can do that may help you stay healthy and manage changes in your thinking. Keeping your mind active is one thing that may benefit your brain. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future. While there are no medications to stop or reverse Alzheimers disease or a related dementia, there are medicines that may help slow down certain symptoms, such as memory loss or behavioral problems. […] The person with MCI may also consider participating in research by joining a clinical trial or study. Many studies are recruiting people with MCI to test early interventions that could slow or stop the progression of cognitive impairment.

• #6 Mild Cognitive Impairment (MCI): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17990-mild-cognitive-impairment

  Mild cognitive impairment (MCI) happens when you have a slight decline in your mental abilities, like memory and completing complex tasks. MCI has several possible causes, some of which are treatable. A healthcare provider can evaluate you for a diagnosis and possible treatment. […] The treatment for MCI depends on the underlying cause if known. However, some cases of MCI from neurodegenerative diseases cant be reversed. But if your mental changes are due to causes like an infection, sleep problems, mood or medication side effects, your healthcare provider will come up with a treatment plan. […] The U.S. Food and Drug Administration (FDA) hasnt currently approved any medications to directly treat mild cognitive impairment. But there are treatment plans that include nonmedication options to improve cognition. They vary based on the underlying cause of MCI. Researchers are hopeful that Alzheimers disease medications could also help with MCI. They are currently studying this. […] Researchers are actively studying treatment options for MCI. You may be able to join a clinical trial. Talk to your provider about your options.

• #7 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability.

• #8 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  The results of 2 large trials with galantamine (GAL-INT-11, GAL-INT-18) were also disappointing. […] According to Winblad et al. the results of GAL-INT-11 and GAL-INT-18 showed a slight but significantly increased mortality risk during treatment with galantamine, suggesting that pharmacological treatment of MCI patients should be undertaken carefully. […] Despite the abovementioned combination with AChEI for the treatment of MCI patients with memantine, no reliable data from an RCT is yet available on the influence of memantine. […] The largest trial investigating Ginkgo Biloba’s impact on the primary and secondary prevention of dementia was also of the highest methodological quality. […] A separate analysis of participants with MCI showed an identical result. […] These findings suggest that the administration of NSAIDs for the secondary prevention of dementia in persons with MCI cannot be recommended at this stage.

• #9 Practice guideline update summary: Mild cognitive impairment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/

  MCI prevalence was 6.7% for ages 6064, 8.4% for 6569, 10.1% for 7074, 14.8% for 7579, and 25.2% for 8084. […] No high-quality evidence exists to support pharmacologic treatments for MCI. In patients with MCI, exercise training (6 months) is likely to improve cognitive measures and cognitive training may improve cognitive measures. […] Clinicians may choose not to offer cholinesterase inhibitors (Level B); if offering, they must first discuss lack of evidence (Level A). […] For patients diagnosed with MCI, clinicians should wean patients from medications that can contribute to cognitive impairment (where feasible and medically appropriate) and treat modifiable risk factors that may be contributing (Level B). […] For patients diagnosed with MCI, clinicians should recommend regular exercise (twice/week) as part of an overall approach to management (Level B). […] In patients with MCI, clinicians may recommend cognitive interventions (Level C).

• #10 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  Without any approved pharmacological treatment and only modest evidence for symptomatic treatment efficacy therapeutic options are severely limited. […] It should be noted that prevention of clinical progression or conversion to dementia, or even the stabilization of the cognitive state (possibly including a persistence of low-grade cognitive deficits) should be regarded as successful treatment. […] Assuming that most MCI patients, especially patients with amnestic MCI have an underlying pathology of AD, it is logical to investigate whether drug treatment strategies for AD might be effective in the treatment of MCI. […] To date, randomized controlled trials (RCTs) have evaluated a variety of substances that have been hypothesized to be useful in AD. […] The results of the so-called InDDEx trial with rivastigmine were reported by Feldman et al.

• #11 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  The results of 2 large trials with galantamine (GAL-INT-11, GAL-INT-18) were also disappointing. […] According to Winblad et al. the results of GAL-INT-11 and GAL-INT-18 showed a slight but significantly increased mortality risk during treatment with galantamine, suggesting that pharmacological treatment of MCI patients should be undertaken carefully. […] Despite the abovementioned combination with AChEI for the treatment of MCI patients with memantine, no reliable data from an RCT is yet available on the influence of memantine. […] The largest trial investigating Ginkgo Biloba’s impact on the primary and secondary prevention of dementia was also of the highest methodological quality. […] A separate analysis of participants with MCI showed an identical result. […] These findings suggest that the administration of NSAIDs for the secondary prevention of dementia in persons with MCI cannot be recommended at this stage.

• #12 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  The results of 2 large trials with galantamine (GAL-INT-11, GAL-INT-18) were also disappointing. […] According to Winblad et al. the results of GAL-INT-11 and GAL-INT-18 showed a slight but significantly increased mortality risk during treatment with galantamine, suggesting that pharmacological treatment of MCI patients should be undertaken carefully. […] Despite the abovementioned combination with AChEI for the treatment of MCI patients with memantine, no reliable data from an RCT is yet available on the influence of memantine. […] The largest trial investigating Ginkgo Biloba’s impact on the primary and secondary prevention of dementia was also of the highest methodological quality. […] A separate analysis of participants with MCI showed an identical result. […] These findings suggest that the administration of NSAIDs for the secondary prevention of dementia in persons with MCI cannot be recommended at this stage.

• #13 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  The results of 2 large trials with galantamine (GAL-INT-11, GAL-INT-18) were also disappointing. […] According to Winblad et al. the results of GAL-INT-11 and GAL-INT-18 showed a slight but significantly increased mortality risk during treatment with galantamine, suggesting that pharmacological treatment of MCI patients should be undertaken carefully. […] Despite the abovementioned combination with AChEI for the treatment of MCI patients with memantine, no reliable data from an RCT is yet available on the influence of memantine. […] The largest trial investigating Ginkgo Biloba’s impact on the primary and secondary prevention of dementia was also of the highest methodological quality. […] A separate analysis of participants with MCI showed an identical result. […] These findings suggest that the administration of NSAIDs for the secondary prevention of dementia in persons with MCI cannot be recommended at this stage.

• #14 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  The results of 2 large trials with galantamine (GAL-INT-11, GAL-INT-18) were also disappointing. […] According to Winblad et al. the results of GAL-INT-11 and GAL-INT-18 showed a slight but significantly increased mortality risk during treatment with galantamine, suggesting that pharmacological treatment of MCI patients should be undertaken carefully. […] Despite the abovementioned combination with AChEI for the treatment of MCI patients with memantine, no reliable data from an RCT is yet available on the influence of memantine. […] The largest trial investigating Ginkgo Biloba’s impact on the primary and secondary prevention of dementia was also of the highest methodological quality. […] A separate analysis of participants with MCI showed an identical result. […] These findings suggest that the administration of NSAIDs for the secondary prevention of dementia in persons with MCI cannot be recommended at this stage.

• #15 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  RCTs that investigated the effect of statins in the secondary prevention of MCI are currently unavailable. […] The results of the cited studies are sobering. […] However, it should be noted that the lack of evidence of an effect of these substances is not necessarily the same as ineffectiveness. […] Patient education should be undertaken cautiously and should take into account that cognitive deficits may remain stable or even remit spontaneously.

• #16 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. […] The medicines are approved for people with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease. Known as monoclonal antibodies, they include:

• #17 Mild cognitive impairment (MCI) | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/mild-cognitive-impairment-mci?content_id=CON-20205683

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. […] The medicines are approved for people with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease. Known as monoclonal antibodies, they include: Lecanemab-irmb (Leqembi) and Donanemab-azbt (Kisunla).

• #18 Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease: The Role for Monoclonal Antibodies

  https://www.psychiatrist.com/pcc/screening-assessment-pharmacologic-treatment-mild-cognitive-impairment-early-alzheimers-disease-role-monoclonal-antibodies/

  The primary cognitive enhancers (donepezil, galantamine, rivastigmine, and memantine) have been available and studied in AD and related dementias for over 25 years. […] Once a patient has reached the moderate stage of AD, memantine is also indicated. […] Cognitive enhancers can be used concurrently and may work synergistically. […] Monoclonal antibodies are laboratory-engineered immunoglobulins that possess a high degree of specificity for a particular antigen or epitope. […] Currently, there are 2 FDA-approved monoclonal antibody-based therapies aimed at targeting A deposits in MCI or early AD. […] The other monoclonal antibody drug that has received FDA approval is lecanemab (Leqembi), an IgG1 monoclonal antibody developed by Eisai, which binds to A-soluble protofibril forms. […] A few months later, Ms B and her daughter return to review the results of neuropsychological testing and brain MRI.

• #19 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. […] The medicines are approved for people with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease. Known as monoclonal antibodies, they include:

• #20 Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner

  https://memory.georgetown.edu/news/lecanumab-leqembitm-fda-approved-for-individuals-with-mild-cognitive-impairment-mci-or-mild-dementia-due-to-alzheimers-disease-ad-collectively-called-early-ad-r-scott-turner/

  Lecanumab (Leqembi) is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. […] Leqembi is the first treatment for individuals with MCI with clear evidence of effectiveness. […] In fact, Leqembi is the first effective new drug for MCI and AD since memantine was approved in 2003. […] The findings of a large phase 3 study of 1,795 participants with MCI or mild AD are clear the rate of cognitive and functional decline is significantly slower in the treatment group compared to the placebo group. […] It should be emphasized however that Leqembi does not reverse cognitive decline it only slows it down. […] Individuals who carry 1 or 2 ApoE4 genes have a higher risk of ARIA-E and ARIA-H. […] Interested and eligible individuals must decide for themselves whether the risk-benefit ratio is favorable after discussion with their healthcare providers.

• #21 Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner

  https://memory.georgetown.edu/news/lecanumab-leqembitm-fda-approved-for-individuals-with-mild-cognitive-impairment-mci-or-mild-dementia-due-to-alzheimers-disease-ad-collectively-called-early-ad-r-scott-turner/

  Lecanumab (Leqembi) is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. […] Leqembi is the first treatment for individuals with MCI with clear evidence of effectiveness. […] In fact, Leqembi is the first effective new drug for MCI and AD since memantine was approved in 2003. […] The findings of a large phase 3 study of 1,795 participants with MCI or mild AD are clear the rate of cognitive and functional decline is significantly slower in the treatment group compared to the placebo group. […] It should be emphasized however that Leqembi does not reverse cognitive decline it only slows it down. […] Individuals who carry 1 or 2 ApoE4 genes have a higher risk of ARIA-E and ARIA-H. […] Interested and eligible individuals must decide for themselves whether the risk-benefit ratio is favorable after discussion with their healthcare providers.

• #22 Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner

  https://memory.georgetown.edu/news/lecanumab-leqembitm-fda-approved-for-individuals-with-mild-cognitive-impairment-mci-or-mild-dementia-due-to-alzheimers-disease-ad-collectively-called-early-ad-r-scott-turner/

  Lecanumab (Leqembi) is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. […] Leqembi is the first treatment for individuals with MCI with clear evidence of effectiveness. […] In fact, Leqembi is the first effective new drug for MCI and AD since memantine was approved in 2003. […] The findings of a large phase 3 study of 1,795 participants with MCI or mild AD are clear the rate of cognitive and functional decline is significantly slower in the treatment group compared to the placebo group. […] It should be emphasized however that Leqembi does not reverse cognitive decline it only slows it down. […] Individuals who carry 1 or 2 ApoE4 genes have a higher risk of ARIA-E and ARIA-H. […] Interested and eligible individuals must decide for themselves whether the risk-benefit ratio is favorable after discussion with their healthcare providers.

• #23 Mild cognitive impairment (MCI) | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/mild-cognitive-impairment-mci

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. Before starting treatment, the FDA recommends getting a brain MRI. […] If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects.

• #24 Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner

  https://memory.georgetown.edu/news/lecanumab-leqembitm-fda-approved-for-individuals-with-mild-cognitive-impairment-mci-or-mild-dementia-due-to-alzheimers-disease-ad-collectively-called-early-ad-r-scott-turner/

  Leqembi is given by intravenous infusion over one hour, every two weeks. […] Healthcare systems and payors including Medicare must decide if the cost-benefit ratio of Leqembi treatment is favorable. […] Leqembi is also being investigated as a potential treatment to prevent the onset of MCI and mild AD in healthy older individuals at risk. […] Leqembi treatment may become the standard of care for those who are interested and eligible. […] With the availability of new effective treatments such as Leqembi, population-wide screening efforts must ramp up. […] The larger goal is to prevent cognitive decline in healthy normal individuals at risk, and to slow or stop decline in the earliest/mild stage of MCI and AD.

• #25 Lecanumab (LeqembiTM) FDA-approved for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) – collectively called early AD R. Scott Turner

  https://memory.georgetown.edu/news/lecanumab-leqembitm-fda-approved-for-individuals-with-mild-cognitive-impairment-mci-or-mild-dementia-due-to-alzheimers-disease-ad-collectively-called-early-ad-r-scott-turner/

  Lecanumab (Leqembi) is the first disease-modifying treatment for individuals with MCI and mild AD with solid evidence of effectiveness. […] Leqembi is the first treatment for individuals with MCI with clear evidence of effectiveness. […] In fact, Leqembi is the first effective new drug for MCI and AD since memantine was approved in 2003. […] The findings of a large phase 3 study of 1,795 participants with MCI or mild AD are clear the rate of cognitive and functional decline is significantly slower in the treatment group compared to the placebo group. […] It should be emphasized however that Leqembi does not reverse cognitive decline it only slows it down. […] Individuals who carry 1 or 2 ApoE4 genes have a higher risk of ARIA-E and ARIA-H. […] Interested and eligible individuals must decide for themselves whether the risk-benefit ratio is favorable after discussion with their healthcare providers.

• #26 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability.

• #27 Mild Cognitive Impairment | Conditions | UCSF Health

  https://www.ucsfhealth.org/conditions/mild-cognitive-impairment

  Currently, there is no specific treatment for mild cognitive impairment (MCI). As new treatments for Alzheimer’s disease are developed, these treatments may be tested on patients with MCI. If experimental treatments help slow cognitive decline, the early diagnosis of MCI will become increasingly important. […] Keep in mind that some drugs may impair memory, especially in the elderly. Examples of these drugs are Valium, Ativan, Benadryl, Tylenol PM and Advil PM that contain Benadryl, Cogentin and many others. A careful assessment of medications is essential. […] Other potential causes for memory impairment, such as vitamin deficiencies or thyroid disease, may be discovered and treated in the evaluation.

• #28 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability.

• #29 Mild cognitive impairment (MCI) | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/mild-cognitive-impairment-mci?content_id=CON-20205683

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Treating these conditions can help improve your memory and overall mental ability. Conditions that can affect memory include high blood pressure, depression, and sleep apnea.

• #30 Mild Cognitive Impairment | Conditions | UCSF Health

  https://www.ucsfhealth.org/conditions/mild-cognitive-impairment

  Currently, there is no specific treatment for mild cognitive impairment (MCI). As new treatments for Alzheimer’s disease are developed, these treatments may be tested on patients with MCI. If experimental treatments help slow cognitive decline, the early diagnosis of MCI will become increasingly important. […] Keep in mind that some drugs may impair memory, especially in the elderly. Examples of these drugs are Valium, Ativan, Benadryl, Tylenol PM and Advil PM that contain Benadryl, Cogentin and many others. A careful assessment of medications is essential. […] Other potential causes for memory impairment, such as vitamin deficiencies or thyroid disease, may be discovered and treated in the evaluation.

• #31 What to Know About Mild Cognitive Impairment Treatment – The New York Times

  https://www.nytimes.com/2024/02/06/well/mind/mild-cognitive-impairment-treatment.html

  Cognitive decline is a frightening prospect for most people. But experts say there are ways to manage and treat it, especially if it’s caught at an early stage, known as mild cognitive impairment. […] Treating M.C.I. can “prolong that period of being independent by months or years,” said Andrew Kiselica, a neuropsychologist at the University of Missouri who specializes in diagnosing dementia. […] The first step to treating M.C.I. is to search for a biological reason for someone’s symptoms using blood tests, brain scans and other clinical assessments. […] Even if the root cause for M.C.I. is a neurodegenerative disease, taking care of some of these “exacerbating causes” can help improve symptoms, said Dr. Halima Amjad, an assistant professor of medicine specializing in geriatrics at the Johns Hopkins University School of Medicine.

• #32 Practice guideline update summary: Mild cognitive impairment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/

  MCI prevalence was 6.7% for ages 6064, 8.4% for 6569, 10.1% for 7074, 14.8% for 7579, and 25.2% for 8084. […] No high-quality evidence exists to support pharmacologic treatments for MCI. In patients with MCI, exercise training (6 months) is likely to improve cognitive measures and cognitive training may improve cognitive measures. […] Clinicians may choose not to offer cholinesterase inhibitors (Level B); if offering, they must first discuss lack of evidence (Level A). […] For patients diagnosed with MCI, clinicians should wean patients from medications that can contribute to cognitive impairment (where feasible and medically appropriate) and treat modifiable risk factors that may be contributing (Level B). […] For patients diagnosed with MCI, clinicians should recommend regular exercise (twice/week) as part of an overall approach to management (Level B). […] In patients with MCI, clinicians may recommend cognitive interventions (Level C).

• #33 Practice guideline update summary: Mild cognitive impairment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/

  MCI prevalence was 6.7% for ages 6064, 8.4% for 6569, 10.1% for 7074, 14.8% for 7579, and 25.2% for 8084. […] No high-quality evidence exists to support pharmacologic treatments for MCI. In patients with MCI, exercise training (6 months) is likely to improve cognitive measures and cognitive training may improve cognitive measures. […] Clinicians may choose not to offer cholinesterase inhibitors (Level B); if offering, they must first discuss lack of evidence (Level A). […] For patients diagnosed with MCI, clinicians should wean patients from medications that can contribute to cognitive impairment (where feasible and medically appropriate) and treat modifiable risk factors that may be contributing (Level B). […] For patients diagnosed with MCI, clinicians should recommend regular exercise (twice/week) as part of an overall approach to management (Level B). […] In patients with MCI, clinicians may recommend cognitive interventions (Level C).

• #34

  https://www.brain.northwestern.edu/dementia/mci/treatment.html

  Mild cognitive impairment (MCI) refers to a condition in which there is a decline in ones cognitive abilities (memory, language and/or reasoning) but not to the extent that it affects routine activities, like banking, driving, managing medication and taking care of usual responsibilities. […] There is no specific medication for mild cognitive impairment at this time. The medications available to Alzheimers disease have been used in some studies, but are not always recommended for MCI. […] Importantly, there are a number of lifestyle modifications that have been shown to help individuals with MCI. These include: Stay active: Keep up with interests. Make modifications when possible to accommodate for short-term memory or other changes. Eat right. Your brain needs proper food and liquid to function normally. Exercise. There is a lot of evidence that aerobic exercise slows cognitive decline. Maintain sleep hygiene and address problems if they exist. Talk with others about your concerns. Let close friends and family know what you are going through so that you may gain their support. […] To help cope with the changes caused by MCI, finding support is very important.

• #35 How to Diagnose & Treat Mild Cognitive Impairment

  https://betterhealthwhileaging.net/qa-how-to-treat-mild-cognitive-impairment/

  Mild cognitive impairment (MCI) means having cognitive abilities (memory and thinking skills) that have become worse than normal for your age. However, the memory or other problems shouldn’t be so bad that you no longer can complete daily life tasks you used to do, such as finances or meal preparation, without assistance. […] In many clinical trials, the goal in treating mild cognitive impairment has been to reduce the risk of progression to Alzheimer’s or another dementia. […] Unfortunately, almost nothing has been proven to work, although some approaches are promising and certain approaches (especially exercise) probably delay the progression to dementia. […] In particular, no oral medications are actually FDA-approved for the treatment of MCI, as none have been shown to prevent progression to dementia.

• #36 How to Diagnose & Treat Mild Cognitive Impairment

  https://betterhealthwhileaging.net/qa-how-to-treat-mild-cognitive-impairment/

  The approach that seems most consistently promising is exercise, although it’s unclear which exercise is best. […] A sensible approach is to include all important types of exercise. That is: aerobic, resistance, balance, and flexibility exercises. […] There is research to suggest that diet plays a role in dementia. However, it’s not yet clear what particular diet will prevent MCI from progressing in most people. […] Some researchers have found that a vitamin B supplement (a combination of folic acid, vitamin B6, and vitamin B12) reduces cognitive decline in MCI. […] A large trial published in 2005 found that vitamin E had no effect on the progression of MCI. […] There are currently no oral medications that have FDA approval for the treatment of MCI. […] However, many doctors prescribe these medications to people with MCI, especially if they have amnestic MCI.

• #37 Mental Exercises For Mild Cognitive Impairment (+ 30 Ideas)

  https://optoceutics.com/mental-exercises-for-mild-cognitive-impairment-decline/?srsltid=AfmBOorMZWv6pPaggTdvtm2lI_L5e2pBOUZaFJJEm0M3eJYC67vnm8w6

  Art therapy is an important adjunct in any activity plan for halting MCI. […] Evidence for the efficacy of music in treating MCI is scarce. However, the studies that have been conducted show that music can be a powerful tool for halting cognitive decline. […] Learning a foreign language, or improving the language skills of the MCI sufferer’s native tongue, is thought to delay the onset of dementia. […] The types of mental and physical activities that can help improve MCI are physical exercise, games and puzzles, taking on a new skill, social engagement, mindfulness and meditation, eating a Mediterranean diet, and having a restful sleep. […] Physical exercise can benefit cognitive health in several ways. It helps increase blood flow to the brain, which can promote the growth of new brain cells and improve brain function.

• #38

  https://www.healthxchange.sg/seniors/ageing-concerns/mild-cognitive-impairment-diagnosis-treatment

  Regular exercise is needed to treat mild cognitive impairment (MCI). […] There are no specific approved drugs for mild cognitive impairment. After your consultation with your doctor, based on findings from your investigations, your doctor may prescribe cholinesterase inhibitors (these are prescribed for Alzheimers disease) to help improve your symptoms. […] At home, you can take some simple steps to prevent further cognitive decline. These include: […] Regular mental exercises can help form and retain cognitive associations, explains Dr Kandiah. Learning new skills such as a language or picking up a musical instrument can also help to increase brain reserve. […] Consider adopting a Mediterranean diet that consists of fish, vegetables, grains and nuts, with some olive oil and moderate amounts of red wine. Omega-3 fatty acids, present in fish, are great for cognitive health. […] Exercise at least three times a week, advises Dr Kandiah. Do a mix of aerobic activities such as jogging and stair-climbing to get your heart pumping, and balance and coordination exercises to help you stay agile.

• #39 Practice guideline update summary: Mild cognitive impairment

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/

  MCI prevalence was 6.7% for ages 6064, 8.4% for 6569, 10.1% for 7074, 14.8% for 7579, and 25.2% for 8084. […] No high-quality evidence exists to support pharmacologic treatments for MCI. In patients with MCI, exercise training (6 months) is likely to improve cognitive measures and cognitive training may improve cognitive measures. […] Clinicians may choose not to offer cholinesterase inhibitors (Level B); if offering, they must first discuss lack of evidence (Level A). […] For patients diagnosed with MCI, clinicians should wean patients from medications that can contribute to cognitive impairment (where feasible and medically appropriate) and treat modifiable risk factors that may be contributing (Level B). […] For patients diagnosed with MCI, clinicians should recommend regular exercise (twice/week) as part of an overall approach to management (Level B). […] In patients with MCI, clinicians may recommend cognitive interventions (Level C).

• #40 Staving off dementia when you have mild cognitive impairment – Harvard Health

  https://www.health.harvard.edu/staying-healthy/staving-off-dementia-when-you-have-mild-cognitive-impairment

  Dr. Salinas says MCI can often be reversed if a general health condition (such as sleep deprivation) is causing the decline. In those cases, addressing the underlying cause can dramatically improve cognition. […] When MCI can’t be reversed, treatment is challenging. There are no pills to slow the worsening of memory problems. […] But the AAN did find encouraging evidence linking exercise with better memory in people with MCI. Exercising can offer mental and social stimulation while improving blood flow to the brain, possibly even prompting the release of molecules that repair brain cells and create connections between them. The new MCI treatment guidelines recommend exercising at least twice a week. […] The AAN also notes that cognitive training may improve thinking skills, although the evidence is weak.

• #41 Mental Exercises For Mild Cognitive Impairment (+ 30 Ideas)

  https://optoceutics.com/mental-exercises-for-mild-cognitive-impairment-decline/?srsltid=AfmBOorMZWv6pPaggTdvtm2lI_L5e2pBOUZaFJJEm0M3eJYC67vnm8w6

  Discover mental exercises for mild cognitive impairment, including brain games, meditation, and physical activity, aimed at enhancing cognitive health and slowing progression. […] Mental exercises like brain games and meditation can slow cognitive decline in mild cognitive impairment. […] Cognitive exercise therapy involves structured activities and exercises designed to improve cognitive function. […] The goal of cognitive exercise therapy is to stimulate the brain and improve cognitive abilities. […] Unfortunately, MCI does not resolve completely with mental exercises. What these exercises do is slow the progression, sometimes enough to ward off the transition to full-blown dementia. […] Studies have shown that the prefrontal cortex and medial temporal cortex, otherwise known as the areas of the brain controlling thinking and memory, increase in volume through exercise.

• #42 Overcoming Mild Cognitive Impairment: Treatment Options and Strategies

  https://occupationaltherapybrisbane.com.au/mild-cognitive-impairment-treatment/

  Cognitive training: Memory training and other cognitive exercises may help improve cognitive function in people with MCI. […] Physical exercise: Regular exercise, especially aerobic exercise, has known benefits for heart health and may also help prevent or slow cognitive decline. […] Social activities and engagement: Being social may help preserve mental function and slow mental decline. […] Healthy diet: While the impact of diet on cognitive decline is still uncertain, a healthy diet that includes fish, vegetables, and black and green teas may be beneficial for overall brain health. […] While these therapies and lifestyle changes may not cure MCI, they can help individuals maintain their cognitive function, improve their quality of life, and potentially slow down the progression of the condition. […] Memory aids and strategies can be helpful for people living with Mild Cognitive Impairment (MCI) to compensate for decreased memory function. […] It is important to note that memory aids and strategies are not meant to treat memory loss but to aid in compensating for it.

• #43

  https://www.healthxchange.sg/seniors/ageing-concerns/mild-cognitive-impairment-diagnosis-treatment

  Regular exercise is needed to treat mild cognitive impairment (MCI). […] There are no specific approved drugs for mild cognitive impairment. After your consultation with your doctor, based on findings from your investigations, your doctor may prescribe cholinesterase inhibitors (these are prescribed for Alzheimers disease) to help improve your symptoms. […] At home, you can take some simple steps to prevent further cognitive decline. These include: […] Regular mental exercises can help form and retain cognitive associations, explains Dr Kandiah. Learning new skills such as a language or picking up a musical instrument can also help to increase brain reserve. […] Consider adopting a Mediterranean diet that consists of fish, vegetables, grains and nuts, with some olive oil and moderate amounts of red wine. Omega-3 fatty acids, present in fish, are great for cognitive health. […] Exercise at least three times a week, advises Dr Kandiah. Do a mix of aerobic activities such as jogging and stair-climbing to get your heart pumping, and balance and coordination exercises to help you stay agile.

• #44

  https://link.springer.com/article/10.1007/s11065-017-9363-3

  Cognitive training in MCI may stimulate pre-existing neural reserves or recruit neural circuitry as compensatory scaffolding prompting neuroplastic reorganization to meet task demands. […] An updated examination regarding the efficacy of cognitive intervention in MCI is needed given improvements in adherence to MCI diagnostic criteria in subject selection, better defined interventions and strategies applied, increased use of neuropsychological measures pre- and post-intervention, as well as identification of moderator variables which may influence treatment. […] Overall, these findings suggest individuals with MCI who received multicomponent training or interventions targeting multiple domains (including lifestyle changes) were apt to display an improvement on outcome measures of cognition post-intervention.

• #45

  https://link.springer.com/article/10.1007/s11065-017-9363-3

  In addition, interventions with memory and multidomain forms of content appear to be particularly helpful, with memory-based approaches possibly being more effective than multidomain methods. […] Given this, although the creation of new primary network paths appears strained in MCI, interventions with memory-based or multidomain forms of content may facilitate partial activation of compensatory scaffolding and neuroplastic reorganization. […] The positive benefit of memory-based strategies may also reflect transfer effects indicative of compensatory network activation and the multiple-pathways involved in memory processes. […] The summary effect observed with multicomponent and multidomain forms of intervention may reflect this process. […] Multicomponent types of cognitive training appear to improve performance on cognitive outcomes for individuals with MCI. […] Significant point estimates in the context of relatively low values on bias indicators infer there was a positive benefit from multicomponent training, although moderate heterogeneity due to the range of strategies, number of outcomes and various settings was present.

• #46 Treatment for Mild Cognitive Impairment: Does It Work?

  https://neuraleffects.com/blog/treatment-for-mild-cognitive-impairment/

  Unfortunately, there is no drug to cure mild cognitive impairment, but some treatment options are available to slow its progression. At Neural Effects, we offer a combination of physical exercise and cognitive therapy an approach proven to slow down the rate of mental decline in patients with mild cognitive impairment. […] One option for patients with mild cognitive impairment involves using multiple therapies in combination, such as cognitive, physical, and occupational therapy. This is not a cure, but it can delay the progression of symptoms. Some patients with MCI even see their symptoms improve after these therapies. […] Therapy is the treatment approach of choice at Neural Effects. We offer a combination of physical exercise and cognitive therapies to maximize results. […] Research has shown that this approach has a more substantial impact on cognitive function than just exercise or cognitive therapy in isolation. Participants in these studies saw improvements in short and long-term memory, executive ability, attention, spatial orientation, and verbal fluency, as well as overall resilience, to name just a few.

• #47 Mild Dementia Treatment What’s Backed by Research

  https://neuraleffects.com/blog/mild-dementia-treatment-therapy/

  Talking therapies including cognitive behavioral therapy, psychotherapy, and counseling are very effective for patients with mild to moderate dementia. […] Occupational therapists work with patients and their families to encourage independent living as much as possible. […] Reminiscence therapy involves talking about memories and past experiences to stimulate cognitive activity and improve quality of life. […] Bright light therapy can help regulate the circadian rhythm and, as a result, improve cognitive function, reduce depressive symptoms, and improve sleep quality. […] Animal-assisted therapy (also called pet therapy) involves the use of animals to help dementia patients. […] Art therapy can be a fun and relaxing way for dementia patients to express their creativity. […] Non-drug approaches like the ones described above can be very effective in delaying the progression of dementia and controlling symptoms such as poor sleep, depression, and low mood.

• #48 Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial | Alzheimer’s Research & Therapy | Full Text

  https://alzres.biomedcentral.com/articles/10.1186/s13195-024-01482-z

  Evidence links lifestyle factors with Alzheimers disease (AD). We report the first randomized, controlled clinical trial to determine if intensive lifestyle changes may beneficially affect the progression of mild cognitive impairment (MCI) or early dementia due to AD. […] Comprehensive lifestyle changes may significantly improve cognition and function after 20 weeks in many patients with MCI or early dementia due to AD. […] We report here results of a randomized controlled trial to determine if the progression of MCI or early dementia due to AD may be slowed, stopped, or perhaps even reversed by a comprehensive, multimodal, intensive lifestyle intervention after 20 weeks when compared to a usual-care randomized control group. This lifestyle intervention includes (1) a whole foods, minimally processed plant-based diet low in harmful fats and low in refined carbohydrates and sweeteners with selected supplements; (2) moderate exercise; (3) stress management techniques; and (4) support groups.

• #49 Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial | Alzheimer’s Research & Therapy | Full Text

  https://alzres.biomedcentral.com/articles/10.1186/s13195-024-01482-z

  Evidence links lifestyle factors with Alzheimers disease (AD). We report the first randomized, controlled clinical trial to determine if intensive lifestyle changes may beneficially affect the progression of mild cognitive impairment (MCI) or early dementia due to AD. […] Comprehensive lifestyle changes may significantly improve cognition and function after 20 weeks in many patients with MCI or early dementia due to AD. […] We report here results of a randomized controlled trial to determine if the progression of MCI or early dementia due to AD may be slowed, stopped, or perhaps even reversed by a comprehensive, multimodal, intensive lifestyle intervention after 20 weeks when compared to a usual-care randomized control group. This lifestyle intervention includes (1) a whole foods, minimally processed plant-based diet low in harmful fats and low in refined carbohydrates and sweeteners with selected supplements; (2) moderate exercise; (3) stress management techniques; and (4) support groups.

• #50 Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial | Alzheimer’s Research & Therapy | Full Text

  https://alzres.biomedcentral.com/articles/10.1186/s13195-024-01482-z

  Evidence links lifestyle factors with Alzheimers disease (AD). We report the first randomized, controlled clinical trial to determine if intensive lifestyle changes may beneficially affect the progression of mild cognitive impairment (MCI) or early dementia due to AD. […] Comprehensive lifestyle changes may significantly improve cognition and function after 20 weeks in many patients with MCI or early dementia due to AD. […] We report here results of a randomized controlled trial to determine if the progression of MCI or early dementia due to AD may be slowed, stopped, or perhaps even reversed by a comprehensive, multimodal, intensive lifestyle intervention after 20 weeks when compared to a usual-care randomized control group. This lifestyle intervention includes (1) a whole foods, minimally processed plant-based diet low in harmful fats and low in refined carbohydrates and sweeteners with selected supplements; (2) moderate exercise; (3) stress management techniques; and (4) support groups.

• #51

  https://www.healthxchange.sg/seniors/ageing-concerns/mild-cognitive-impairment-diagnosis-treatment

  Regular exercise is needed to treat mild cognitive impairment (MCI). […] There are no specific approved drugs for mild cognitive impairment. After your consultation with your doctor, based on findings from your investigations, your doctor may prescribe cholinesterase inhibitors (these are prescribed for Alzheimers disease) to help improve your symptoms. […] At home, you can take some simple steps to prevent further cognitive decline. These include: […] Regular mental exercises can help form and retain cognitive associations, explains Dr Kandiah. Learning new skills such as a language or picking up a musical instrument can also help to increase brain reserve. […] Consider adopting a Mediterranean diet that consists of fish, vegetables, grains and nuts, with some olive oil and moderate amounts of red wine. Omega-3 fatty acids, present in fish, are great for cognitive health. […] Exercise at least three times a week, advises Dr Kandiah. Do a mix of aerobic activities such as jogging and stair-climbing to get your heart pumping, and balance and coordination exercises to help you stay agile.

• #52 Mild Cognitive Impairment | Pacific Brain Health Center

  https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/mild-cognitive-impairment/

  Healthy dietary practices. A Mediterranean or MIND diet, rich in fruits, vegetables, olive oil, legumes, whole grains and fish offer many heart-healthy and brain-healthy benefits) […] Heart healthy behaviors. Control of blood pressure, cholesterol, blood sugars and smoking cessation offer additional benefits for brain health and cognitive vitality […] Enhancing mental activities. Cognitive stimulation such as reading, writing, learning a new language and other novel activities help to enhance brain agility improving function […] Socializing. People who engage in regular social events and practices have better and more sustained cognitive functioning with age than those individuals who are more socially isolated.

• #53

  https://www.healthxchange.sg/seniors/ageing-concerns/mild-cognitive-impairment-diagnosis-treatment

  Regular exercise is needed to treat mild cognitive impairment (MCI). […] There are no specific approved drugs for mild cognitive impairment. After your consultation with your doctor, based on findings from your investigations, your doctor may prescribe cholinesterase inhibitors (these are prescribed for Alzheimers disease) to help improve your symptoms. […] At home, you can take some simple steps to prevent further cognitive decline. These include: […] Regular mental exercises can help form and retain cognitive associations, explains Dr Kandiah. Learning new skills such as a language or picking up a musical instrument can also help to increase brain reserve. […] Consider adopting a Mediterranean diet that consists of fish, vegetables, grains and nuts, with some olive oil and moderate amounts of red wine. Omega-3 fatty acids, present in fish, are great for cognitive health. […] Exercise at least three times a week, advises Dr Kandiah. Do a mix of aerobic activities such as jogging and stair-climbing to get your heart pumping, and balance and coordination exercises to help you stay agile.

• #54 State of the science on mild cognitive impairment (MCI) | CNS Spectrums | Cambridge Core

  https://www.cambridge.org/core/journals/cns-spectrums/article/state-of-the-science-on-mild-cognitive-impairment-mci/9E28EC622A1911D82E18E4023811D79D

  The approaches described in the remainder of this section are not cures, and no one holds the belief that these measures will have direct effects on the neuropathological changes occurring in MCI, but there is still reason to think that they may delay progression to dementia. […] Physical exercise interventions have shown small but significant neural and cognitive benefits for cognition in people with MCI. […] Adherence to Mediterranean-style dietary patterns has been associated with a reduced risk of MCI and AD in epidemiological studies. […] Another approach to increase reserve and everyday functioning in people with MCI is group psychosocial education. […] The MCI guidelines also highlight the need to educate patients and families about MCI, and suggest that clinicians should counsel patients and families. […] In addition to these more comprehensive intervention approaches, a number of investigators are discovering the best approaches to memory interventions for MCI.

• #55 Mild cognitive impairment (MCI) | Dementia Australia

  https://www.dementia.org.au/brain-health/mild-cognitive-impairment-mci

  Researchers are testing drugs used to treat Alzheimers disease, but its not certain yet if they are good treatments for MCI. […] Right now, there is no effective medical treatment for mild cognitive impairment. But there are changes that can potentially delay the progression of MCI, including: Exercise regularly: even going for a walk helps. If youre not able to exercise or youre at risk of falls, talk to your doctor about getting help from an exercise physiologist. Eat a balanced, nutritious diet to support your brain health. There is evidence to suggest that a dietary supplement called Souvenaid can support brain function in people with mild cognitive impairment. […] Souvenaid should be standard of care, I believe, for people who have mild cognitive impairment due to Alzheimer’s disease. And in the not very distant future now, we’ll have anti-amyloid, and potentially disease-modifying therapies that can be used for people both to prevent mild cognitive impairment in those who are at risk of developing it, but also, to prevent progression from mild cognitive impairment to the dementia stage.

• #56 How to Diagnose & Treat Mild Cognitive Impairment

  https://betterhealthwhileaging.net/qa-how-to-treat-mild-cognitive-impairment/

  The approach that seems most consistently promising is exercise, although it’s unclear which exercise is best. […] A sensible approach is to include all important types of exercise. That is: aerobic, resistance, balance, and flexibility exercises. […] There is research to suggest that diet plays a role in dementia. However, it’s not yet clear what particular diet will prevent MCI from progressing in most people. […] Some researchers have found that a vitamin B supplement (a combination of folic acid, vitamin B6, and vitamin B12) reduces cognitive decline in MCI. […] A large trial published in 2005 found that vitamin E had no effect on the progression of MCI. […] There are currently no oral medications that have FDA approval for the treatment of MCI. […] However, many doctors prescribe these medications to people with MCI, especially if they have amnestic MCI.

• #57 Staving off dementia when you have mild cognitive impairment – Harvard Health

  https://www.health.harvard.edu/staying-healthy/staving-off-dementia-when-you-have-mild-cognitive-impairment

  Dr. Salinas says people with MCI can take a cue from these types of findings to maintain as many healthy habits as possible. That includes not only exercising, eating right, and staying connected with other people, but also engaging in mentally stimulating activities (particularly learning new things, like a new hobby or new language) and taking medications as prescribed. […] There are no guarantees, but the evidence suggests these steps may delay or even prevent progression to dementia. „The people who spend the most time cognitively stable are often the ones who stick to lifestyle recommendations,” says Dr. Salinas.

• #58

  https://umiamihealth.org/en/treatments-and-services/neurology/memory-disorders/mild-cognitive-impairment

  A recent study concluded that cognitive training leads to clinically meaningful improvements in overall cognition, as well as working memory, processing speed and executive functions. […] Some studies do show that incorporating elements of exercise may provide added benefit than do programs that are purely cognitive in nature. […] Indeed, one study demonstrated that patients who received a multifaceted program comprising cognitive, transfer and motor elements improved over those receiving cognitive training alone or cognitive plus transfer training only. […] Patients should engage in activities that challenge their brain to learn new things, think creatively, solve problems and achieve goals. Activities such as exercising, reading, using the computer, solving puzzles, playing games, engaging in social interactions and even performing household chores may promote cognitive preservation. To stay sharp, patients should stay active socially, physically and mentally.

• #59

  https://umiamihealth.org/en/treatments-and-services/neurology/memory-disorders/mild-cognitive-impairment

  Patients with mild cognitive impairment (MCI) experience a decline in memory but not in other cognitive abilities. There is no significant impact on daily life. It often goes unnoticed by the individual experiencing it, but a person with MCI remains at a greater risk of progressing on to dementia. […] Although research is active, to date, there are no FDA-approved treatments for MCI. […] For this reason, there is a great interest in non-pharmacological approaches to stave off worsening cognitive disability. One such approach is cognitive training, which researchers believe may allow the brain to reorganize its pathways to adjust to new situations and compensate for injury or disease. […] In recent years, there has been an explosion of clinical trials investigating the merits of cognitive training. Various forms of cognitive training have been reported to have positive effects on executive functions, attention, memory, information processing speed and visual spatial abilities.

• #60 Mild cognitive impairment (MCI) treatment in London, UK

  https://www.psychiatrycentre.co.uk/treatments/mild-cognitive-impairment-mci/

  We live in a world where an increasing number of our elders are suffering with dementia. This heartbreaking disease often begins with Mild Cognitive Impairment (MCI). Although there is currently no standard approved treatment for mild cognitive impairment, at The London Psychiatry Centre, we provide rTMS following a specialised cognitive protocol designed to maximise benefits for patients with MCI before it develops into dementia. For individuals with MCI, early intervention with rTMS could be a crucial step in slowing cognitive decline and improving quality of life. […] Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive treatment that uses magnetic pulses to stimulate nerve cells in the brain. Originally developed for depression, rTMS has shown promise in treating cognitive disorders, including MCI. This is particularly exciting as there are limited treatments currently available for preventing the progression of MCI to dementia.

• #61 Redefining treatment for mild cognitive impairment  | MUSC | Charleston, SC

  https://web.musc.edu/about/news-center/2023/07/27/tms-for-mild-cognitive-impairment

  With more than $3.7 million in funding from the National Institute on Aging, Medical University of South Carolina neuropsychologist Andreana Benitez, Ph.D., of the Department of Neurology in the College of Medicine will lead a phase II clinical trial to determine the optimal dose of transcranial magnetic stimulation, or TMS, needed to improve symptoms for patients with depression and mild cognitive impairment, or MCI. […] In this study, the MUSC team will be using intermittent theta-burst TMS delivered in an accelerated treatment course: Participants will choose six TMS treatment days within a two-week period, each lasting about 2 hours. Such an accelerated treatment course could be less burdensome for older adults with MCI. […] Depression is common in the older population and especially in those with MCI. When applied to the front left side of the brain, TMS is already approved by the FDA for the treatment of major depressive disorder. The new MUSC study aims to find the optimal dose to improve both depression and thinking difficulties in MCI.

• #62 Navigating Mild Cognitive Impairment: Prevention and Treatment | Hebrew SeniorLife

  https://www.hebrewseniorlife.org/blog/navigating-mild-cognitive-impairment-prevention-and-treatment

  The good news is there are steps you can take to prevent or slow mild cognitive impairment. With the right tools, people can become resilient to conditions that threaten healthy aging. We know that modifiable risk factors account for 40 percent of worldwide dementias and therefore brain health is in many ways in our control. You can influence the trajectory of your brain health with the lifestyle choices you make. […] Evidence suggests that it is very important to regularly stimulate your brain in new and demanding ways. Being willing to be a beginner again and learn new things provides cognitive training, which boosts cognitive reserve. To optimize the benefits, neurostimulation treatment, such as transcranial magnetic stimulation or transcranial current stimulation can also be used in conjunction with cognitive training.

• #63 What Is Mild Cognitive Impairment (MCI), and How Is It Treated?

  https://www.expressable.com/learning-center/adults/what-is-mild-cognitive-impairment-mci-and-how-is-it-treated

  Speech therapy can help mild cognitive impairment. […] If MCI is diagnosed, your doctor will discuss treatment options to help manage your symptoms and enable you to maintain independence for a longer period of time. Speech therapy is often recommended. […] Your speech therapist will complete a thorough assessment to identify areas of strength and areas for improvement. They will then work with you to strengthen your skills and teach you strategies to use in your everyday life. […] These are just some examples of the many things you can learn and improve with the help of a speech therapist. […] Regardless of where a person is in the progression of MCI or dementia, speech therapy helps improve quality of life. The ultimate goal of speech therapy is to help people independently perform daily tasks, communicate clearly, and connect with others.

• #64 Mental Exercises For Mild Cognitive Impairment (+ 30 Ideas)

  https://optoceutics.com/mental-exercises-for-mild-cognitive-impairment-decline/?srsltid=AfmBOorMZWv6pPaggTdvtm2lI_L5e2pBOUZaFJJEm0M3eJYC67vnm8w6

  Art therapy is an important adjunct in any activity plan for halting MCI. […] Evidence for the efficacy of music in treating MCI is scarce. However, the studies that have been conducted show that music can be a powerful tool for halting cognitive decline. […] Learning a foreign language, or improving the language skills of the MCI sufferer’s native tongue, is thought to delay the onset of dementia. […] The types of mental and physical activities that can help improve MCI are physical exercise, games and puzzles, taking on a new skill, social engagement, mindfulness and meditation, eating a Mediterranean diet, and having a restful sleep. […] Physical exercise can benefit cognitive health in several ways. It helps increase blood flow to the brain, which can promote the growth of new brain cells and improve brain function.

• #65 Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) | Mount Sinai – New York

  https://www.mountsinai.org/clinical-trials/music-therapy-experiences-in-patients-with-mild-cognitive-impairment-mci-alzheimers-disease-ad

  This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer’s disease and Mild Cognitive Impairment. […] The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer’s disease and Mild Cognitive Impairment. […] Following screening, all participants will meet with a licensed music therapist at the first study visit. […] Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. […] Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

• #66 Navigating Mild Cognitive Impairment: Prevention and Treatment | Hebrew SeniorLife

  https://www.hebrewseniorlife.org/blog/navigating-mild-cognitive-impairment-prevention-and-treatment

  At the Wolk Center, we offer care for those who are concerned about possible memory loss, including strategies to optimize quality of life and cognitive function, such as neuromodulation and cognitive stimulation, as well as in-home technology, app-based games, and exercises to promote cognitive reserve. We specialize in prevention of cognitive decline, early diagnosis, specific subtype diagnosis, ongoing care for managing dementia, and more.

• #67 Mild Cognitive Impairment (MCI): How Constant Therapy can help

  https://constanttherapyhealth.com/brainwire/mild-cognitive-impairment-mci-how-constant-therapy-can-help/

  “I always recommend Constant Therapy for my clients and caregivers of those clients who have been diagnosed with MCI. It provides an accessible and immediately actionable way for them to address the cognitive challenges that come along with MCI.” – Constant Therapy clinician in a skilled nursing facility […] If you or a loved one are diagnosed with MCI, Constant Therapy can help overcome those challenges associated with MCI. […] In addition, Constant Therapy may help to overcome many of the challenges that MCI creates. Preliminary research has shown encouraging results that Constant Therapy may help patients with MCI maintain their cognitive skills. […] However, there are some things you can do if you are diagnosed with MCI, and one of those is to regularly practice science-based cognitive exercises with Constant Therapy.

• #68 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] In some cases, memory and thinking problems may be caused by conditions that are treatable. For example, a bad reaction to medication, emotional problems, drinking too much alcohol, blood clots or tumors in the brain, or a head injury can all cause serious memory problems that can be resolved with treatment. […] There is currently no treatment or medication for MCI, but there are things you can do that may help you stay healthy and manage changes in your thinking. Keeping your mind active is one thing that may benefit your brain. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future. While there are no medications to stop or reverse Alzheimers disease or a related dementia, there are medicines that may help slow down certain symptoms, such as memory loss or behavioral problems. […] The person with MCI may also consider participating in research by joining a clinical trial or study. Many studies are recruiting people with MCI to test early interventions that could slow or stop the progression of cognitive impairment.

• #69 Diagnosing and getting treatment for MCI | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/mild-cognitive-impairment-treatments

  Getting treatment for mild cognitive impairment […] There are currently no medicines that are licensed to treat MCI or which reduce the chances of developing dementia. Symptoms can sometimes improve when a health problem thats contributing to the condition is treated effectively. This might involve a referral to another specialist clinic, such as a sleep clinic or mental health service. However, for many people its not clear what is causing their MCI and so the best option may be to wait and see. […] […] Once a person has been told they have MCI they will often be referred back to the care of their GP. If their condition gets worse, the GP will refer them back to the memory service for a follow-up assessment. The memory service should also direct a person with MCI to local sources of support, where these are available. […] […] If MCI has developed into dementia, then the memory service may be able to help with medicines and other support.

• #70 Mild Cognitive Impairment (MCI) | Symptoms & Treatments | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is an early stage of memory loss or other cognitive ability loss (such as language or visual/spatial perception) in individuals who maintain the ability to independently perform most activities of daily living. […] Mild cognitive impairment causes cognitive changes that are serious enough to be noticed by the person affected and by family members and friends but do not affect the individuals ability to carry out everyday activities. […] Donanemab (Kisunla) and lecanemab (Leqembi) have received traditional approval by the U.S. Food and Drug Administration for the treatment of early Alzheimer’s disease. […] These therapies address the underlying biology of Alzheimers and slow disease progression. […] More research is needed on the biological changes associated with normal aging, MCI and Alzheimers and other dementias to better understand the causes of and risk factors for MCI and the prognosis for those with the condition. […] Individuals who have been diagnosed with MCI should be reevaluated every six months to determine if symptoms have progressed.

• #71

  https://continentalhospitals.com/diseases/mild-cognitive-impairment/

  One important aspect of treating MCI is lifestyle modifications. This includes engaging in regular physical exercise, maintaining a healthy diet, and getting enough sleep. These lifestyle changes have been shown to have positive effects on cognitive function and overall brain health. Cognitive stimulation activities are also recommended as part of the treatment plan for individuals with MCI. These activities can include puzzles, memory games, reading, or learning a new skill. They help keep the brain active and may improve cognitive abilities. In some cases, medication may be prescribed to manage symptoms associated with MCI. However, it’s important to note that there is no specific medication approved for treating MCI itself. Medications may be used to address underlying conditions such as depression or anxiety that can worsen cognitive impairment. Lastly, regular follow-up appointments with healthcare professionals are crucial in monitoring the progression of MCI and adjusting treatment plans accordingly. It’s important for individuals with MCI to work closely with their healthcare team to develop a personalized treatment approach that suits their needs. Overall, while there is no cure for mild cognitive impairment at present, early detection and proactive management can significantly improve quality of life and potentially delay further decline in cognitive function. Treatment strategies focus on lifestyle modifications, cognitive stimulation activities, medication management if necessary, and ongoing monitoring by healthcare professionals.

• #72 Mild cognitive impairment – TauRx

  https://taurx.com/medical-professionals/mild-cognitive-impairment

  Investigating tau-based interventions to halt or slow progression of MCI […] There has been additional research over the past decade to develop treatments that target protein aggregates in the brain, which may potentially slow progression of Alzheimers disease if used early in the diseases pathology. […] It also presents the only opportunity for early intervention as emerging treatments become available to slow the diseases progression. […] Early intervention is key, especially in cases where MCI may progress to more serious conditions like Alzheimers disease.

• #73 Diagnosing and getting treatment for MCI | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/mild-cognitive-impairment-treatments

  Getting treatment for mild cognitive impairment […] There are currently no medicines that are licensed to treat MCI or which reduce the chances of developing dementia. Symptoms can sometimes improve when a health problem thats contributing to the condition is treated effectively. This might involve a referral to another specialist clinic, such as a sleep clinic or mental health service. However, for many people its not clear what is causing their MCI and so the best option may be to wait and see. […] […] Once a person has been told they have MCI they will often be referred back to the care of their GP. If their condition gets worse, the GP will refer them back to the memory service for a follow-up assessment. The memory service should also direct a person with MCI to local sources of support, where these are available. […] […] If MCI has developed into dementia, then the memory service may be able to help with medicines and other support.

• #74 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] In some cases, memory and thinking problems may be caused by conditions that are treatable. For example, a bad reaction to medication, emotional problems, drinking too much alcohol, blood clots or tumors in the brain, or a head injury can all cause serious memory problems that can be resolved with treatment. […] There is currently no treatment or medication for MCI, but there are things you can do that may help you stay healthy and manage changes in your thinking. Keeping your mind active is one thing that may benefit your brain. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future. While there are no medications to stop or reverse Alzheimers disease or a related dementia, there are medicines that may help slow down certain symptoms, such as memory loss or behavioral problems. […] The person with MCI may also consider participating in research by joining a clinical trial or study. Many studies are recruiting people with MCI to test early interventions that could slow or stop the progression of cognitive impairment.

• #75 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] In some cases, memory and thinking problems may be caused by conditions that are treatable. For example, a bad reaction to medication, emotional problems, drinking too much alcohol, blood clots or tumors in the brain, or a head injury can all cause serious memory problems that can be resolved with treatment. […] There is currently no treatment or medication for MCI, but there are things you can do that may help you stay healthy and manage changes in your thinking. Keeping your mind active is one thing that may benefit your brain. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future. While there are no medications to stop or reverse Alzheimers disease or a related dementia, there are medicines that may help slow down certain symptoms, such as memory loss or behavioral problems. […] The person with MCI may also consider participating in research by joining a clinical trial or study. Many studies are recruiting people with MCI to test early interventions that could slow or stop the progression of cognitive impairment.

• #76 Mild cognitive impairment – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/care-at-mayo-clinic/mac-20354587

  Mayo Clinic neurologists, mental health specialists (psychiatrists and psychologists), imaging specialists (radiologists), sleep medicine specialists and others work together to diagnose and treat people with mild cognitive impairment. […] Your healthcare professional works with you to develop a treatment plan appropriate for you and your family’s needs. […] Mayo Clinic doctors conduct extensive research on mild cognitive impairment, Alzheimer’s disease and other dementias, and conduct clinical trials. You may have an opportunity to participate in a clinical trial as part of your treatment at Mayo Clinic. […] Mayo Clinic researchers actively study mild cognitive impairment, Alzheimer’s disease and other conditions that affect your memory and thinking skills.

• #77 Mild cognitive impairment – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/care-at-mayo-clinic/mac-20354587

  Mayo Clinic neurologists, mental health specialists (psychiatrists and psychologists), imaging specialists (radiologists), sleep medicine specialists and others work together to diagnose and treat people with mild cognitive impairment. […] Your healthcare professional works with you to develop a treatment plan appropriate for you and your family’s needs. […] Mayo Clinic doctors conduct extensive research on mild cognitive impairment, Alzheimer’s disease and other dementias, and conduct clinical trials. You may have an opportunity to participate in a clinical trial as part of your treatment at Mayo Clinic. […] Mayo Clinic researchers actively study mild cognitive impairment, Alzheimer’s disease and other conditions that affect your memory and thinking skills.

• #78 Mild Cognitive Impairment (MCI): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17990-mild-cognitive-impairment

  Mild cognitive impairment (MCI) happens when you have a slight decline in your mental abilities, like memory and completing complex tasks. MCI has several possible causes, some of which are treatable. A healthcare provider can evaluate you for a diagnosis and possible treatment. […] The treatment for MCI depends on the underlying cause if known. However, some cases of MCI from neurodegenerative diseases cant be reversed. But if your mental changes are due to causes like an infection, sleep problems, mood or medication side effects, your healthcare provider will come up with a treatment plan. […] The U.S. Food and Drug Administration (FDA) hasnt currently approved any medications to directly treat mild cognitive impairment. But there are treatment plans that include nonmedication options to improve cognition. They vary based on the underlying cause of MCI. Researchers are hopeful that Alzheimers disease medications could also help with MCI. They are currently studying this. […] Researchers are actively studying treatment options for MCI. You may be able to join a clinical trial. Talk to your provider about your options.

• #79 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  Mild cognitive impairment (MCI) is a syndrome which, depending on various neurobiological, psychological and social factors, carries a high risk of developing into dementia. […] As far as diagnostic uncertainty and the heterogeneous underlying pathophysiological mechanisms are concerned, only limited therapeutic options are currently available. […] For MCI as a prodromal syndrome of AD, clinical trials with disease modifying drugs that target underlying pathological mechanisms such as amyloid-beta accumulation and neurofibrillary tangle formation may help develop effective treatment options in the future. […] Nevertheless, a lack of approved pharmacotherapeutic options has led to specific interventions that focus on patient education and life-style related factors receiving increasing attention.

• #80 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Treatment for mild cognitive impairment may include medicines for Alzheimer’s disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues. […] Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia. […] Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. […] The medicines are approved for people with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease. Known as monoclonal antibodies, they include:

• #81 Treatment for Mild Cognitive Impairment: Does It Work?

  https://neuraleffects.com/blog/treatment-for-mild-cognitive-impairment/

  Unfortunately, there is no drug to cure mild cognitive impairment, but some treatment options are available to slow its progression. At Neural Effects, we offer a combination of physical exercise and cognitive therapy an approach proven to slow down the rate of mental decline in patients with mild cognitive impairment. […] One option for patients with mild cognitive impairment involves using multiple therapies in combination, such as cognitive, physical, and occupational therapy. This is not a cure, but it can delay the progression of symptoms. Some patients with MCI even see their symptoms improve after these therapies. […] Therapy is the treatment approach of choice at Neural Effects. We offer a combination of physical exercise and cognitive therapies to maximize results. […] Research has shown that this approach has a more substantial impact on cognitive function than just exercise or cognitive therapy in isolation. Participants in these studies saw improvements in short and long-term memory, executive ability, attention, spatial orientation, and verbal fluency, as well as overall resilience, to name just a few.

• #82 Overcoming Mild Cognitive Impairment: Treatment Options and Strategies

  https://occupationaltherapybrisbane.com.au/mild-cognitive-impairment-treatment/

  MCI treatment aims to help people with minor memory or thinking issues, often in older age. Its not a normal part of aging. […] Treatment includes lifestyle changes like staying mentally and physically active, a healthy diet, and managing other health conditions. […] Regular health check-ups with a doctor are crucial and connecting with specialised therapies are vital. […] Prevention of MCI is possible and in some case reversible, where research suggests that maintaining: An active lifestyle, healthy diet, and managing blood pressure, blood sugar, and cholesterol levels may help reduce the risk. […] Overall, non-pharmacological treatments show promise in addressing cognitive and behavioural symptoms of MCI, and yes, more rigorous studies are necessary to establish their efficacy and identify optimal intervention types.

• #83 Mild Cognitive Impairment (MCI): Pathogenesis and Treatments

  https://www.cpn.or.kr/journal/view.html?uid=64&vmd=Full

  Mild cognitive impairment (MCI), poorly defined for many years, has recently been described as a transition state from healthy cognitive ageing into dementia. […] Clinical trials with existing compounds have failed to find any positive effects on MCI treatment. […] To overcome current failures in MCI therapeutics, future research should focus on better understanding the etiology of this condition and developing new compounds based on such knowledge.

• #84 Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3580783/

  Mild cognitive impairment (MCI) is a syndrome which, depending on various neurobiological, psychological and social factors, carries a high risk of developing into dementia. […] As far as diagnostic uncertainty and the heterogeneous underlying pathophysiological mechanisms are concerned, only limited therapeutic options are currently available. […] For MCI as a prodromal syndrome of AD, clinical trials with disease modifying drugs that target underlying pathological mechanisms such as amyloid-beta accumulation and neurofibrillary tangle formation may help develop effective treatment options in the future. […] Nevertheless, a lack of approved pharmacotherapeutic options has led to specific interventions that focus on patient education and life-style related factors receiving increasing attention.

• #85 Mild cognitive impairment – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/care-at-mayo-clinic/mac-20354587

  Mayo Clinic neurologists, mental health specialists (psychiatrists and psychologists), imaging specialists (radiologists), sleep medicine specialists and others work together to diagnose and treat people with mild cognitive impairment. […] Your healthcare professional works with you to develop a treatment plan appropriate for you and your family’s needs. […] Mayo Clinic doctors conduct extensive research on mild cognitive impairment, Alzheimer’s disease and other dementias, and conduct clinical trials. You may have an opportunity to participate in a clinical trial as part of your treatment at Mayo Clinic. […] Mayo Clinic researchers actively study mild cognitive impairment, Alzheimer’s disease and other conditions that affect your memory and thinking skills.

Zobacz więcej